InsidersTradesSigma
Track the 아이엠바이오로직스 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 아이엠바이오로직스 has published 7 public disclosures. Market capitalisation: €258.3bn. The latest transaction was reported on 30 March 2026 (Purchase). Among the most active insiders: 아이엠엠인베스트먼트. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
7 of 7 declarations
아이엠바이오로직스 es una empresa del sector de la salud y farmacéutico, cotizada en el mercado XKRX. Se especializa en el desarrollo de soluciones biológicas innovadoras.